Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Ineffective Pneumococcal Vaccine in Children

Open Forum Infect Dis; ePub 2018 Feb 17; Martin, et al

Although initial changes in Haemophilus influenzae colonization of children’s nasopharynxes may have suggested that pneumococcal conjugate vaccines (PCVs) are having an impact among children with acute otitis media, over time those increases have not been sustained, according to 4 separate studies.

  • Among children in cohort 1, who were recruited before routine use of PCV7, colonization with vaccine serotypes of H. influenzae was 26%.
  • In cohort 2, 93% of whom received ≥2 doses of the vaccine, and cohort 3, all of whom received it, colonization reached 41% and 33% respectively.
  • But cohort 4, all of whom received ≥2 or more doses of PCV13, colonization had dropped to 29%.


Martin JM, Hoberman A, Shaikh N, et al. Changes over time in nasopharyngeal colonization in children under 2 years of age at the time of diagnosis of acute otitis media (1999–2014). [Published online ahead of print February 17, 2018]. Open Forum Infect Dis. doi:10.1093/ofid/ofy036.

This Week's Must Reads

USPSTF: Screening for Prostate Cancer, JAMA; 2018 May 8; Grossman, et al

Smoke-Free Policies and Risk of CVD , Circulation; ePub 2018 May 7; Mayne, et al

Psychological Interventions & Chronic Pain Reduction, JAMA Intern Med; ePub 2018 May 7; Niknejad, et al

Managing Blood Pressure in a Primary Care Setting, J Am Board Fam Med; 2018 May-Jun; Doane, et al

Cancer Incidence Rates in HIV-Infected Adults, Ann Intern Med; ePub 2018 May 8; Shiels, et al

Must Reads in Vaccines

Does an Adult Tdap Booster Makes Sense?, J Pediatr Infect Dis Soc; 2018 Feb 8; Halperin, et al

Vaccine Exposure & Non-Vaccine Related Infection, JAMA Pediatr; 2018 Mar 6; Glanz, et al

Developing Cost Effective Typhoid Fever Vaccines , J Infect Dis; ePub 2018 Feb 12; Lo, Gupta, et al

Ineffective Pneumococcal Vaccine in Children, Open Forum Infect Dis; ePub 2018 Feb 17; Martin, et al

Genetically Redesigned RSV Vaccine is Promising , J Infect Dis; ePub 2018 Mar 2; Buchholz, et al